Abstract

The interaction of the incoming beam radiation with the patient body in hadrontherapy treatments produces secondary charged and neutral particles, whose detection can be used for monitoring purposes and to perform an on-line check of beam particle range. In the context of ion-therapy with active scanning, charged particles are potentially attractive since they can be easily tracked with a high efficiency, in presence of a relatively low background contamination. In order to verify the possibility of exploiting this approach for in-beam monitoring in ion-therapy, and to guide the design of specific detectors, both simulations and experimental tests are being performed with ion beams impinging on simple homogeneous tissue-like targets (PMMA). From these studies, a resolution of the order of few millimeters on the single track has been proven to be sufficient to exploit charged particle tracking for monitoring purposes, preserving the precision achievable on longitudinal shape. The results obtained so far show that the measurement of charged particles can be successfully implemented in a technology capable of monitoring both the dose profile and the position of the Bragg peak inside the target and finally lead to the design of a novel profile detector. Crucial aspects to be considered are the detector positioning, to be optimized in order to maximize the available statistics, and the capability of accounting for the multiple scattering interactions undergone by the charged fragments along their exit path from the patient body. The experimental results collected up to now are also valuable for the validation of Monte Carlo simulation software tools and their implementation in Treatment Planning Software packages.

Highlights

  • The use of particle therapy (PT) is becoming more and more effective for the treatment of solid cancer

  • The measurements performed with a small polymethyl methacrylate (PMMA) target (4 cm thickness) at LNS using a carbon beam with 80 MeV/u energy, confirmed that a significant production of charged fragments occurs in Bragg peak (BP) proximity [29]

  • Using the same beam and detector conditions employed in the real case scenario simulation shown in Figure 13, the attenuation of protons emitted at 90° with respect to the beam incoming direction has been obtained for PMMA as a function of the thickness of material crossed by the fragments

Read more

Summary

INTRODUCTION

The use of particle therapy (PT) is becoming more and more effective for the treatment of solid cancer. The spatial distribution of charged particles emitted at large angle by a tissue-equivalent target irradiated by a therapeutic beam has to be measured accurately in order to exploit the correlation with the longitudinal dose profile and, with the BP position. These measurements have to be performed as a function of different projectile types and energies, characterizing the yield of the different produced fragments and their angular distribution.

CHARGED PARTICLES PRODUCTION BY THERAPEUTIC BEAMS
Small Angle Production
Large Angle Production
E Prod kin
The Charged Particles Emission Distribution
An Application to the Clinical Environment
Findings
CONCLUDING REMARKS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.